Acadia Pharmaceuticals (ACAD) Reports Q2 Loss, Lags Revenue Estimates

Acadia (ACAD) delivered earnings and revenue surprises of -13.33% and -1.58%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock? …read more

Source:: Yahoo Finance

Discover Tomorrow’s Winning Stocks!
Get our latest stock reports before everyone else! Actionable news, and breakout stocks w multi-bagger upside potential — delivered directly to your inbox.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.